Artificial Intelligence

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.

As AI tools multiply, Cloudhands emerges with a unified platform and veteran leadership, promising to end the chaos of juggling multiple models.

Dr. Lu Xianping, crowned EY Entrepreneur Of The Year, didn't just invent new drugs; he helped reinvent China's entire pharmaceutical industry.

At CES 2026, Seyond debuts its Hummingbird solid-state LiDAR with a major OEM win, challenging rivals in a race to define the future of autonomy.

FeatherSnap heads to CES 2026 with its AI bird feeders, highlighting the smart home's expansion into nature, citizen science, and a competitive market.

All eyes are on Sandisk's Jan 29 report. Can the reborn flash memory leader meet lofty expectations and prove its post-spin-off strategy is a success?

With a major funding round, Biobeat aims to replace bulky cuffs with a discreet patch, potentially revolutionizing hypertension care for millions.

With strong financials and new clinical data, medical device leader Penumbra is set to detail its growth strategy at healthcare's top investor event.

After a year of major acquisitions and AI-driven innovation, all eyes are on Labcorp's strategic vision for 2026 at the J.P. Morgan Healthcare Conference.

Treace Medical heads to the J.P. Morgan conference to showcase its surgical tech, facing tough questions on growth amid competition and market shifts.

As 10x Genomics preps for its J.P. Morgan spotlight, investors seek a clear path to profit amid fierce competition and groundbreaking innovation.

Sidus Space nets nearly $15M in a new offering to scale satellite production and defense tech, sparking investor optimism despite financial pressures.

With CEO David Endicott set to present at the J.P. Morgan Healthcare Conference, all eyes are on Alcon's strategy for innovation and market growth.

Amidst legal industry fears of generative AI, BriefCatch's $6M funding and stellar retention prove the value of a trusted, specialized AI writing partner.

Amid market volatility and a green energy push, Devon's CEO will outline the firm's strategy for navigating a complex 2026 at a top industry event.

SOLAI shareholders approved a massive 30 billion share increase, arming the firm for a radical pivot into AI and the Solana ecosystem. But what about dilution?

As data centers face an energy crisis fueled by AI, Aradatum is commercializing a unique vertical wind turbine promising a dense, low-cost power solution.

Fresh off a successful IPO, Ceribell is set to showcase its revolutionary AI-powered EEG system, a device already changing outcomes in ICUs nationwide.

New Era Energy & Digital faces a major fraud lawsuit from New Mexico over abandoned oil wells, threatening its pivot to a high-tech data center future.

Transit-tech firm Argo gets a $1.4M boost from TheVentureCity, a fund led by a former Facebook colleague of Argo's CEO, to scale its smart city solutions.